Sotirios Katsamakas
Sotirios Katsamakas
Department of Pharmaceutical Chemistry, Aristotle University of Thessaloniki
Verified email at
Cited by
Cited by
Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site
T Tomasic, S Katsamakas, Z Hodnik, J Ilaš, M Brvar, T Solmajer, ...
Journal of medicinal chemistry 58 (14), 5501-5521, 2015
Discovery of benzothiazole scaffold-based DNA gyrase B inhibitors
M Gjorgjieva, T Tomašič, M Barančokova, S Katsamakas, J Ilaš, ...
Journal of medicinal chemistry 59 (19), 8941-8954, 2016
RGD-mediated delivery of small-molecule drugs
S Katsamakas, T Chatzisideri, S Thysiadis, V Sarli
Future medicinal chemistry 9 (6), 579-604, 2017
Synthesis and biological evaluation of a platinum (II)-c (RGDyK) conjugate for integrin-targeted photodynamic therapy
T Chatzisideri, S Thysiadis, S Katsamakas, P Dalezis, I Sigala, ...
European journal of medicinal chemistry 141, 221-231, 2017
Synthesis and evaluation of gallocyanine dyes as potential agents for the treatment of Alzheimer's disease and related neurodegenerative tauopathies
S Mpousis, S Thysiadis, N Avramidis, S Katsamakas, S Efthimiopoulos, ...
European journal of medicinal chemistry 108, 28-38, 2016
Advances of phenoxazines: synthesis, reactivity and their medicinal applications
S Katsamakas, A L Zografos, V Sarli
Current medicinal chemistry 23 (26), 2972-2999, 2016
Interaction of Fe (III) with herbicide-carboxylato ligands–Di-, tri-and tetra-nuclear compounds: Structure and magnetic behavior
C Dendrinou-Samara, S Katsamakas, C Raptopoulou, A Terzis, ...
Polyhedron 26 (4), 763-772, 2007
Synthesis, structure elucidation and biological evaluation of triple bridged dinuclear copper (II) complexes as anticancer and antioxidant/anti-inflammatory agents
Z Boulsourani, S Katsamakas, GD Geromichalos, V Psycharis, ...
Materials Science and Engineering: C 76, 1026-1040, 2017
Boronic acid group: A cumbersome false negative case in the process of drug design
S Katsamakas, AG Papadopoulos, D Hadjipavlou-Litina
Molecules 21 (9), 1185, 2016
Considering autotaxin inhibitors in terms of 2D-QSAR and 3D-mapping-review and evaluation
S Katsamakas, E Bermperoglou, D Hadjipavlou-Litina
Current medicinal chemistry 22 (12), 1428-1461, 2015
Novel c (RGDyK)-based conjugates of POPAM and 5-fluorouracil for integrin-targeted cancer therapy
S Thysiadis, S Katsamakas, P Dalezis, T Chatzisideri, D Trafalis, V Sarli
Future medicinal chemistry 9 (18), 2181-2196, 2017
Mononuclear copper (II) complexes with 2-thiophene carboxylate and NN donors; DNA interaction, antioxidant/anti-inflammatory and antitumor activity
Z Boulsourani, GD Geromichalos, S Katsamakas, V Psycharis, ...
Materials Science and Engineering: C 94, 493-508, 2019
Design and synthesis of gallocyanine inhibitors of dkk1/lrp6 interactions for treatment of alzheimer’s disease
S Thysiadis, S Katsamakas, S Mpousis, N Avramidis, S Efthimiopoulos, ...
Bioorganic chemistry 80, 230-244, 2018
Targeting on poly (ADP‐ribose) polymerase activity with DNA‐damaging hybrid lactam‐steroid alkylators in wild‐type and BRCA1‐mutated ovarian cancer cells
DT Trafalis, A Polonifi, P Dalezis, N Nikoleousakos, S Katsamakas, V Sarli
Chemical biology & drug design 90 (5), 854-866, 2017
Discovery of novel phenoxazinone derivatives as DKK1/LRP6 interaction inhibitors: Synthesis, biological evaluation and structure–activity relationships
S Thysiadis, S Mpousis, N Avramidis, S Katsamakas, A Balomenos, ...
Bioorganic & medicinal chemistry 24 (5), 1014-1022, 2016
Sulfanyl 5H-dihydropyrrole derivatives via 1, 3-dipolar cycloaddition, their further chemical manipulation and antioxidant activity.
K Oikonomou, D Georgiou, S Katsamakas, D Hadjipavlou-Litina, ...
ARKIVOC: Online Journal of Organic Chemistry 2015, 2015
Examining barbiturate scaffold for the synthesis of new agents with biological interest
S Katsamakas, AG Papadopoulos, MG Kouskoura, CK Markopoulou, ...
Future medicinal chemistry 11 (16), 2063-2079, 2019
α-Amination and the 5-exo-trig cyclization reaction of sulfur-containing Schiff bases with N-phenyltriazolinedione and their anti-lipid peroxidation activity
E Pelit, K Oikonomou, M Gul, D Georgiou, S Szafert, S Katsamakas, ...
Comptes Rendus Chimie 20 (4), 424-434, 2017
Boronic acid based inhibitors of autotaxin: understanding their biological role in terms of quantitative structure activity relationships (QSAR)
S Katsamakas, D Hadjipavlou-Litina
Letters in Drug Design & Discovery 10 (1), 11-18, 2013
V1-Methyl-8-phenyl-1, 3-diazaspiro [4.5] decane-2, 4-dione
V Pardali, S Katsamakas, E Giannakopoulou, G Zoidis
Molbank 2021 (2), M1228, 2021
The system can't perform the operation now. Try again later.
Articles 1–20